Chris Gard and Connie Yates had fought for months against a London hospital's recommendation that the child be taken off the life support he needs to stay alive with a rare mitochondrial condition.
On Wednesday, July 26, the lawyer representing Charlie Gard's parents reportedly told U.K.'s High Court, a doctor has offered to provide Charlie's necessary care at home or in a hospice.
At yesterday's hearing, the parents' lawyer Grant Armstrong told the London High Court that they had found a doctor who was willing to look after the baby at home or in a hospice. It has suggested that he should be removed from life support within hours of being transferred to a hospice.
He said on Wednesday that the time had come for a decision to be made.
The latest legal row began when the hospital said it was not practical to get the equipment the child needs into the family home, as his ventilator is unable to fit through the front door. "May I pay tribute to those nurses for volunteering", he said.
The care plan for Charlie must honour his parents wishes about the time and place of his passing, but also be safe, spare Charlie all pain and protect his dignity, the hospital said in a statement issued on Tuesday.
"It is in Charlie's best interests to be moved to a hospice and for him at that point to be moved to a palliative care regime only", the judge said as a medical and legal battle that has drawn global attention nears a wrenching conclusion.
Mr Armstrong said Great Ormond Street bosses were not satisfied that a properly qualified specialist would be in charge under the couple's plan.
It was previously determined Charlie will be moved to a hospice and taken off life support "shortly after" if no agreement was met.
The judge said he envisaged Thursday's proceedings being "the final hearing", in a case which has been going through the courts for five months.
In May, the Court of Appeal upheld the ruling, and judges for the European Court of Human Rights declined to intervene in June. His parents just on Monday announced they were giving up their legal fight against the hospital and their own government to obtain treatment.
Michio Hirano, MD, chief of the division of neuromuscular disorders and director of the H. Houston Merritt Clinical Research Center at New York City-based Columbia University Medical Center, traveled to London last week to examine Charlie and determine if he may be a candidate for an experimental treatment. The test will be whether Judge Nicholas Francis is convinced it's in the child's best interest, as British law requires. It's known to cause brain damage and muscle weakness.